CClinicalTrials.gg
CompletedNCT01979029POTLCAORCSUpdated Jun 6, 2016Results posted

Study of the Preservation of the Left Colic Artery on Rectum Cancer Surgery

An interventional study of preserving the left colic artery and not preserving the left colic artery in Rectum Cancer, sponsored by Jian Suo. Completed at 1 site in China. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2016-06-06.

Sponsored by Jian Suo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
57
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

To evaluate the influence to the blood supply of the anastomosis and the harvest of the No. 253 lymph nodes in different surgical methods--- preserving the left colic artery (LCA) and resect the No. 253 lymph node specifically in the radical resection of rectal carcinoma or dividing at the root of the inferior mesenteric artery (IMA) in the radical resection of rectal carcinoma.

Read the detailed description

Methods: The patients who got rectal carcinoma are divided into two groups. Both groups will receive the radical resection of rectal carcinoma. We preserve the left colic artery and resect the No. 253 lymph node specifically in Group A and divide at the root of the inferior mesenteric artery in Group B, We insert a trocar into the arterial arcade at the proximal site of the anastomosis and measure the blood pressure of the arterial arcade in the operation, which can reflect the blood supply of the anastomosis. Besides, We will measure the length of the colon from the anastomosis to the level of the root of the IMA. Expecting Results:The blood pressure of the arterial arcade in Group A will be higher than that in Group B. And the patients in Group A will have less chance to get anastomotic fistula. Expecting Conclusions: Preserving the LCA and resecting the No. 253 lymph node specifically in the radical resection of rectal carcinoma can improve the blood supply of the anastomosis and decrease the incidence of anastomotic fistula, and won't affect the harvest of the No. 253 lymph node.

02

Conditions studied

  • Rectum Cancer

Browse trials for

03

In context

Rectal Neoplasms

1,762 studies on the registry are indexed under Rectal Neoplasms; 518 are open to participants now.

This study's enrollment of 57 is below the median of 65 across 1,298 interventional studies indexed under Rectal Neoplasms.

Browse Rectal Neoplasms studies →

Lead sponsor

Jian Suo is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients coming to FirstJilinU diagnosed rectum cancer by endoscopy and pathology.
  • The rectum cancer is the first malignant neoplasm the patient has got.
  • The cancer is solitary, and is 3cm to 20cm to the anus.
  • The surgical method is limited to Dixon.

Exclusion criteria

Exclusion Criteria:

  • Being in the acute phase of inflammation before operation and emergency surgery.
  • Patients receiving steroid medication or preoperative radiotherapy。
  • Discovering macrometastasis before or in the operation.
  • The rectum cancer that can't be radical resected.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
57 participants (actual)

Study arms

  • Experimental
    preserving the left colic artery

    We preserve the left colic artery and resect the No. 253 lymph node during the rectal surgery.

    Procedure: preserving the left colic artery

  • Experimental
    not preserving the left colic artery

    We preserve the high ligation of the inferior mesenteric artery during the rectal surgery.

    Procedure: not preserving the left colic artery

Interventions

  • Procedurepreserving the left colic artery

    The root of the inferior mesenteric artery(IMA) was carefully dissected and the artery wall was exposed all the way to the bifurcation of the left colic artery(LCA) and the superior rectal artery (SRA), exposing the LCA from its root until the inferior mesenteric vein (IMV) was recognized. Subsequently, dissection was continued along the IMV up to the level of the root of the IMA. Then the sigmoid mesentery was transected from the root of the IMA to the IMV, and the IMV and the root of the SRA were ligated. Finally, the adipose tissue with the lymph nodes in the area surrounded by the IMA, IMV, and LCA was dissected, with preservation of the LCA .

  • Procedurenot preserving the left colic artery

    The root of the IMA was exposed and the fatty tissue around the root of the IMA was swept in order to maximize the lymph node retrieval rate. Subsequently, the IMA was ligated 1 cm from the aorta to avoid damaging the nerves.

06

What researchers measure

Primary outcomes

  1. The Blood Pressure of the Arterial Arcade

    Time frame: after ligating the inferior mesentric artery or superior rectal artery

Secondary outcomes

  1. Distal Colon Length

    Time frame: after digestive tract reconstruction

Other outcomes

  1. Systemic Blood Pressure

    Time frame: after ligating the inferior mesentric artery and measuring the blood pressure of the marginal artery of distal colon

07

Results

Posted Jun 6, 2016

Participant flow

69 Chinese patients from the First Hospital of Jilin University were recruited for the study between February 2013 and December 2013 .

Participant flow — Overall Study
MilestoneHigh Ligation of IMALeft Colic Artery Preserved
Started2928
Completed2928
Not completed00

Outcome measures

PrimaryThe Blood Pressure of the Arterial Arcade
Time frame:
after ligating the inferior mesentric artery or superior rectal artery
Reported as:
Mean · mmHg
The Blood Pressure of the Arterial Arcade
mmHgHigh Ligation of IMALeft Colic Artery Preserved
The Blood Pressure of the Arterial Arcade42.31 ± 1.8548.50 ± 2.48
SecondaryDistal Colon Length
Time frame:
after digestive tract reconstruction
Reported as:
Mean · cm
Distal Colon Length
cmHigh Ligation of IMALeft Colic Artery Preserved
Distal Colon Length20.03 ± 3.2721.29 ± 4.91
Other pre-specifiedSystemic Blood Pressure
Time frame:
after ligating the inferior mesentric artery and measuring the blood pressure of the marginal artery of distal colon
Reported as:
Mean · mmHg
Systemic Blood Pressure
mmHgHigh Ligation of IMALeft Colic Artery Preserved
Systemic Blood Pressure82.86 ± 10.1781.21 ± 11.58

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
High Ligation of IMA—3/29 (10.3%)0/29 (0%)
Left Colic Artery Preserved—1/28 (3.6%)0/28 (0%)
Most frequent serious events
Most frequent serious events
EventHigh Ligation of IMALeft Colic Artery Preserved
anastomotic leakageSurgical and medical procedures3/291/28

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)High Ligation of IMALeft Colic Artery PreservedTotal
<=18 years000
Between 18 and 65 years221739
>=65 years71118
Age, Continuous
Age, Continuous(years)High Ligation of IMALeft Colic Artery PreservedTotal
Mean59.3 (34 to 71)62.1 (45 to 81)60.7 (34 to 81)
Sex: Female, Male
Sex: Female, Male(Participants)High Ligation of IMALeft Colic Artery PreservedTotal
Female131124
Male161733
Region of Enrollment
Region of Enrollment(participants)High Ligation of IMALeft Colic Artery PreservedTotal
China292857
08

Study locations

1 site
  • First Hospital of Jilin University
    Changchun, Jilin 130021, China
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01979029
Lead sponsor
Jian Suo
Responsible party
Jian Suo (Headmaster, Dept.of General Surgery, The First Hospital of Jilin University) — Sponsor-investigator
First posted
Nov 8, 2013
Start date
Feb 2013
Primary completion
Sep 2014
Completion
Oct 2014
Results posted
Jun 6, 2016
Last update
Jun 6, 2016

Study contacts

Jian Suo, Dr.
study chair · Department of Gastrointestinal Surgery, First Hospital of Jilin University, Changchun, China.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion